TOMOCUBE (475960.KQ) — Stock Score Summary

TOMOCUBE (475960.KQ) has a MoatMap StockRank of 31/100 based on Quality (47/100), Value (36/100), and Momentum (35/100) factor scores. The current signal is SELL.

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software.

Key Financial Metrics

Price$25.05
Market Cap$325M
P/E (Forward)33.62
Price/Book13.00
Return on Equity-8.7%
Return on Invested Capital-11.9%
Debt/Equity2.69
Gross Margin65.6%
Operating Margin-67.9%
Revenue Growth320.6%
Free Cash Flow$-969.95

TOMOCUBE operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is TOMOCUBE’s (475960.KQ) StockRank?
MoatMap’s StockRank for TOMOCUBE (475960.KQ) is 31/100, with a Sell signal. It is a composite of Quality (47), Value (36), and Momentum (35) factor ranks across MoatMap’s 19,000+ stock universe.
Does TOMOCUBE have an economic moat?
TOMOCUBE (475960.KQ) has a Quality factor score of 47/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TOMOCUBE a buy, hold, or sell?
MoatMap’s current signal for TOMOCUBE (475960.KQ) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TOMOCUBE in?
TOMOCUBE (475960.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks475960.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock